Skip to main content
Immuron Limited (ASX:IMC)
Australia flag Australia · Delayed Price · Currency is AUD
0.0320
0.00 (0.00%)
Mar 10, 2026, 2:48 PM AEST

Immuron Revenue

Immuron had revenue of 4.18M AUD in the half year ending December 31, 2025, with 77.64% growth. This brings the company's revenue in the last twelve months to 7.48M, up 14.30% year-over-year. In the fiscal year ending June 30, 2025, Immuron had annual revenue of 7.29M with 48.63% growth.

Revenue (ttm)
7.48M
Revenue Growth
+14.30%
P/S Ratio
1.40
Revenue / Employee
1.07M
Employees
7
Market Cap
10.45M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20257.29M2.38M48.63%
Jun 30, 20244.90M3.10M171.67%
Jun 30, 20231.80M1.04M135.85%
Jun 30, 2022765.19K619.42K424.91%
Jun 30, 2021145.78K-2.37M-94.21%
Jun 30, 2020 Pro Pro Pro
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Tissue Repair 3.38M
Invex Therapeutics 229.08K
Chimeric Therapeutics 9.75M
Bio-Gene Technology 390.63K
AdAlta 608.07K
Biotron -868.00
Vectus Biosystems 89.96K
Zelira Therapeutics 656.00
Revenue Rankings

Immuron News

More News